Sign In
Buy MEDS
$7.59
+0 (+0%)
At Close: Dec 19, 2024
TRxADE Health (NASDAQ:MEDS), Newly Merged With Superlatus, To Acquire The Urgent Company to Expand its Reach In The Sustainable Foods Market
09:45am, Wednesday, 06'th Sep 2023
NEW YORK, NY / ACCESSWIRE / September 6, 2023 / TRxADE Health, Inc. (NASDAQ:MEDS), known for its pharmaceutical exchange platform, has recently merged with Superlatus, Inc., a leading food technology
Superlatus Innovates $151 Billion US Snacking Market with Pulse-Based Protein Twists Under the Brave Robot Brand
08:05am, Thursday, 24'th Aug 2023
TAMPA, FL, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Superlatus Inc. ('Superlatus' or the 'Company') recently merged with TRxADE HEALTH, Inc. (NASDAQ: MEDS) and is gearing up to revolutionize the snack indust
TAMPA, FL, Aug. 22, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc. (NASDAQ: MEDS), a pharmaceutical exchange platform provider that recently merged with food technology and distribution company Superlat
TRxADE HEALTH, Inc. Announces Extension of Form 10-Q Filing
10:25am, Monday, 14'th Aug 2023
TAMPA, FL, Aug. 14, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc. (NASDAQ: MEDS) (“TRxADE”), a pharmaceutical exchange platform provider, today announced that it has filed for an extension to file
Newly merged Entity Superlatus, Inc with Trxade Health, Inc. Appoints Leading CPG Management Team
09:05am, Thursday, 03'rd Aug 2023
TAMPA, FL, Aug. 03, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc (NASDAQ: MEDS), parent company of pharmaceutical B2B exchange platform, which recently merged with Superlatus, Inc today announced the a
TRxADE HEALTH, INC. to Report Q2 2023 Financial Results on Monday, August 14th at 6:00 p.m.
04:15pm, Monday, 31'st Jul 2023
TAMPA, FL / ACCESSWIRE / July 31, 2023 / TRxADE HEALTH INC. (NASDAQ:MEDS), is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the pr
TRxADE HEALTH, Inc. Announces Closing of Acquisition of Superlatus, Inc.
08:35am, Monday, 31'st Jul 2023
NEW YORK, July 31, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc. (NASDAQ: MEDS) (“TRxADE”), a pharmaceutical exchange platform provider, today announced the closing of the previously announced acqu
TRxADE HEALTH, Inc. Amends Definitive Merger Agreement with Superlatus, Inc.
04:30pm, Friday, 14'th Jul 2023
NEW YORK, July 14, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc. (NASDAQ: MEDS) (“TRxADE”), a pharmaceutical exchange platform provider, announced today that it entered into an amended and restated
Why Is Trxade Health (MEDS) Stock Down 13% Today?
09:11am, Tuesday, 27'th Jun 2023
Trxade Health (NASDAQ: MEDS ) stock is falling on Tuesday after the company announced it would undergo a merger with Superlatus . That merger will see Trxade Health distribute 3,839,176 shares of MEDS
TRxADE Health (MEDS) Stock Soars 60% on Reverse Split
01:27pm, Thursday, 22'nd Jun 2023
One of the biggest movers in today's market is little-known health tech company TRxADE Health (NASDAQ: MEDS ). Shares of MEDS stock have rocketed more than 60% higher as of this writing on an otherwis
TRxADE HEALTH, Inc. (MEDS) Q1 2023 Earnings Call Transcript
10:30pm, Monday, 15'th May 2023
TRxADE HEALTH, Inc. (NASDAQ:MEDS ) Q1 2023 Earnings Conference Call May 15, 2023 6:00 PM ET Company Participants Prashant Patel - Interim Chief Financial Officer Suren Ajjarapu - Founder, Chairman and
TRxADE (MEDS) Reports Q1 Loss, Lags Revenue Estimates
07:45pm, Monday, 15'th May 2023
TRxADE (MEDS) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to loss of $0.12 per share a year ago.
TRxADE HEALTH, INC. to Report Q1 2023 Financial Results on Monday, May 15th at 6:00 p.m.
04:15pm, Friday, 05'th May 2023
TAMPA, FL / ACCESSWIRE / May 5, 2023 / TRxADE HEALTH INC. (NASDAQ:MEDS) , is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the pre
TRxADE HEALTH, INC. to Report Q1 2023 Financial Results on Monday, May 8th at 5:00 p.m.
12:20am, Tuesday, 25'th Apr 2023
TAMPA, FL / ACCESSWIRE / April 25, 2023 / TRxADE HEALTH INC. (NASDAQ:MEDS), is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the p
TRxADE HEALTH, Inc. (MEDS) Q4 2022 Earnings Call Transcript
09:30pm, Monday, 27'th Mar 2023
TRxADE HEALTH, Inc. (NASDAQ:MEDS ) Q4 2022 Earnings Conference Call March 27, 2023 5:30 PM ET Company Participants Prashant Patel - CFO Surendra Ajjarapu - Founder, Chairman and CEO Conference Call Pa
